The Cigna Group financials

  1. Home
  2. Financials
  3. CI
CI CIK 0001739940

Source: EDGAR filings · Built 2026-06-02T02:38:50Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EBITDA 11.97B 12.19B 11.57B 11.39B 10.86B 10.96B
Working Capital -8.53B -9.11B -11.37B -11.10B -7.44B -8.22B
Net Debt 23.20B 22.27B 22.02B 22.64B 28.07B 21.04B
Gross Margin 21.79% 26.15% 31.48% 30.85% 32.47% 35.48%
Operating Margin 3.35% 3.81% 4.37% 4.68% 4.56% 5.08%
Net Margin 2.17% 1.39% 2.64% 3.76% 3.11% 5.29%
Return on Equity (ROE) 14.28% 8.37% 11.17% 15.18% 11.50% 16.87%
Return on Assets (ROA) 3.77% 2.20% 3.38% 4.71% 3.50% 5.46%
Current Ratio 0.85× 0.84× 0.77× 0.73× 0.83× 0.77×
Debt-to-Equity 0.74× 0.73× 0.65× 0.64× 0.70× 0.62×
Effective Tax Rate 19.19% 28.30% 2.56% 19.23% 20.18% 21.89%
Cash Conversion Ratio 1.61× 3.02× 2.29× 1.28× 1.33× 1.22×
Accruals Ratio -0.02× -0.04× -0.04× -0.01× -0.01× -0.01×
SBC % of Revenue 0.11% 0.12% 0.15% 0.15% 0.15% 0.18%

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 12.41× 22.78× 17.22× 15.48× 14.58× 9.07×
EV / EBITDA 7.99× 8.03× 9.47× 10.68× 9.41× 8.66×
P/S 0.26× 0.31× 0.45× 0.55× 0.43× 0.46×
P/B 1.74× 1.84× 1.90× 2.22× 1.57× 1.47×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 274.90B 247.12B 195.26B 180.52B 174.07B 160.40B
Cost of Goods and Services Sold 214.99B 182.51B 133.80B 124.83B 117.55B 103.48B
Selling, General and Administrative Expense 14.62B 14.84B 14.82B 13.17B 13.01B 14.07B
Operating Income (Loss) 9.20B 9.42B 8.54B 8.45B 7.94B 8.15B
Income Tax Expense (Benefit) 1.49B 1.49B 141.00M 1.61B 1.37B 2.38B
Net Income (Loss) Attributable to Parent 5.96B 3.43B 5.16B — — —
Earnings Per Share, Basic $22.33 $12.25 $17.57 $21.66 $15.89 $23.17
Earnings Per Share, Diluted $22.18 $12.12 $17.39 $21.41 $15.75 $22.96
Weighted Average Number of Shares Outstanding, Diluted 268.56M 283.22M 296.88M 313.06M 340.97M 368.39M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 7.68B 7.55B 7.82B 5.92B 5.08B 10.18B
Assets, Current 47.81B 48.87B 37.35B 30.12B 36.13B 27.80B
Assets 157.92B 155.88B 152.76B 143.88B 154.89B 155.45B
Liabilities, Current 56.34B 57.98B 48.72B 41.23B 43.57B 36.02B
Liabilities 116.05B 114.64B 106.41B 99.13B 107.70B 105.06B
Stockholders' Equity Attributable to Parent 41.71B 41.03B 46.22B 44.67B 47.11B 50.32B
Common Stock, Shares, Outstanding 263.46M 273.79M 292.50M 298.68M 322.95M 354.77M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 9.60B 10.36B 11.81B 8.66B 7.19B 10.35B
Net Cash Provided by (Used in) Investing Activities -4.41B -2.10B -5.17B 3.10B -3.61B 2.98B
Payments for Repurchase of Common Stock 3.62B 7.03B 2.28B 7.61B 7.74B 4.04B
Net Cash Provided by (Used in) Financing Activities -6.42B -7.65B -4.29B -11.24B -8.21B -8.53B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CI CIK 0001739940), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

OCGN

OCUGEN, INC.

XENE

XENON PHARMACEUTICALS INC.

ETSY

ETSY, INC